Skip to main content
. 2008 Dec 1;31(12):1629–1637. doi: 10.1093/sleep/31.12.1629

Figure 3.

Figure 3

Non-mu opioid and GABAA receptors modulate acetylcholine (ACh) release in the principal sensory trigeminal nucleus (PSTN). A. The significant (*) increase in PSTN ACh release caused by morphine (MSO4) was not blocked by the opioid antagonist naloxone (MSO4 + Nal) but was blocked by coadministration of the kappa opioid antagonist nor-binaltorphimine (MSO4 + norBNI). B. Relative to control (dialysis with Ringer's solution), the GABAA receptor antagonist bicuculline significantly (*) increased ACh release in the PSTN. The data in A and B were obtained from 12 rats, and each drug condition summarizes results from 3 rats.